Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?
- PMID: 28505216
- DOI: 10.1001/jamaneurol.2017.0563
Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?
Comment in
-
Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply.JAMA Neurol. 2017 Jul 1;74(7):872. doi: 10.1001/jamaneurol.2017.0566. JAMA Neurol. 2017. PMID: 28505236 No abstract available.
Comment on
-
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.JAMA Neurol. 2017 Feb 1;74(2):189-196. doi: 10.1001/jamaneurol.2016.4480. JAMA Neurol. 2017. PMID: 28027337
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical